GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human Fab CAP256-VRC26.10, a potent V1V2-directed HIV-1 neutralizing antibody

Analyse Crystal structure of human Fab CAP256-VRC26.10, a potent V1V2-directed HIV-1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4OCS
Type
protein
Length
442 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CAP256-VRC26.10 light chain; CAP256-VRC26.10 heavy chain
Pockets
5 · best druggability 0.44

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LCAP256-VRC26.10 light chainprotein2126% helix, 50% strand—
HCAP256-VRC26.10 heavy chainprotein2308% helix, 49% strand—

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.440.8121empty
21700.430.7428empty
31110.380.7425empty
4620.280.7416empty
5510.260.7312empty

Interfaces

1 interface between chains.

  • L–H · 1735 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 4OCS · Crystal structure of human Fab CAP256-VRC26.10, a potent V1V2-directed HIV-1 neutralizing… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.